What question did this study set out to answer?

The central aim is to examine financial obstacles to immunotherapy and propose strategies to address them.

March 5, 20260 citations

Financial barriers to immunotherapy: challenges and potential mitigation strategies: a review paper.

HNHasan NumanAmerican University of Beirut Medical Center ATArafat TfayliAmerican University of Beirut Medical Center

Key Points

The central aim is to examine financial obstacles to immunotherapy and propose strategies to address them.
Review existing literature on financial barriers to immunotherapy.
Analyze dose-optimization strategies and their impact on costs and efficacy.
Evaluate potential for international collaborations in research.
Cost-reduction is possible through dose-optimization without losing clinical effectiveness.
Validated reduced dosing can improve access to immunotherapy.
International partnerships may enhance research efforts in low- and middle-income countries (LMICs).

Abstract

Dose-optimization strategies can reduce costs without compromising clinical efficacy, especially where financial barriers threaten continuity of care. Priorities include, prospective trials validating reduced dosing and international partnerships to integrate LMICs into research.

问 AI

Bookmark

View Full Paper